Showing results (101-110 of 164) with videos related to
Sort By:
Pageof 17
JTO Clinical and Research Reports|January 26, 2026
Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 TrialNiels Reinmuth, Sébastien Couraud, Luis Paz-Ares, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapyMaciej Krzakowski, Rodryg Ramlau, Jacek Jassem, et al.Anticancer Research|December 7, 2016
Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07Dolores Isla, Enriqueta Felip, Nuria Viñolas, et al.Lung Cancer (Amsterdam, Netherlands)|January 3, 2024
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancerByoung Chul Cho, Chao-Hua Chiu, Erminia Massarelli, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 17, 2026
Recommendations for the development of an integrated lung cancer care process: an expert consensus reportMargarita Majem, Patricia Alonso-Fernández, Pilar Garrido López, et al.Lung Cancer (Amsterdam, Netherlands)|August 26, 2019
An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancerDaniel Morgensztern, Nina Karaseva, Enriqueta Felip, et al.Histopathology|August 18, 2017
Aligning digital CD8+ scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinomaEsther Conde, Alejandra Caminoa, Carolina Dominguez, et al.JTO Clinical and Research Reports|August 14, 2025
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB-IIIA NSCLCJay M Lee, Jean-Louis Pujol, Jun Zhang, et al.Nature Medicine|August 12, 2022
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trialVivek Subbiah, Philippe A Cassier, Salvatore Siena, et al.Lung Cancer (Amsterdam, Netherlands)|April 25, 2013
Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: mature results of the Spanish Lung Cancer Group 0008 studyPilar Garrido, Rafael Rosell, Antonio Arellano, et al.Pageof 17